Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:CHAQ

Chardan Healthcare Acquisition 2 (CHAQ) Stock Price, News & Analysis

Chardan Healthcare Acquisition 2 logo

About Chardan Healthcare Acquisition 2 Stock (NYSE:CHAQ)

Key Stats

Today's Range
N/A
50-Day Range
$7.73
$10.65
52-Week Range
N/A
Volume
14,313 shs
Average Volume
55,653 shs
Market Capitalization
$34.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CHAQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chardan Healthcare Acquisition 2 and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CHAQ Stock News Headlines

Warren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the Nasdaq
New Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split the entire U.S. market in two on or before Sept 30, causing a crisis "many times worse than 2008."tc pixel
Century Therapeutics price target lowered to $11 from $17 at Chardan
See More Headlines

CHAQ Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Chardan Healthcare Acquisition 2 investors own include Joint (JYNT), Avino Silver & Gold Mines (ASM), Actinium Pharmaceuticals (ATNM), Biomerica (BMRA), Churchill Capital Corp IV (CCIV), Clearside Biomedical (CLSD) and Gores Holdings IV (GHIV).

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NYSE:CHAQ
CIK
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$780 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-81.39%
Return on Assets
-0.75%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.13
Quick Ratio
0.13

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.54) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
10,778,000
Free Float
N/A
Market Cap
$34.49 million
Optionable
Not Optionable
Beta
0.05
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:CHAQ) was last updated on 9/18/2025 by MarketBeat.com Staff
From Our Partners